Back to News
Market Impact: 0.5

AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?

AHCONVST
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?

AdaptHealth Corp. (AHCO) is set to report Q2 2025 earnings on August 5, with consensus estimates projecting a year-over-year decline in EPS to $0.15 and revenues to $804.53 million. Despite this, Zacks' analysis, combining a positive Earnings ESP of +13.33% and a Zacks Rank #3, suggests AHCO is highly likely to beat consensus EPS estimates. This prediction, supported by the company's historical record of exceeding EPS expectations in three of the last four quarters, positions AHCO as a compelling candidate for an upside surprise, which could positively influence its near-term stock performance.

Analysis

AdaptHealth Corp. (AHCO) is approaching its Q2 2025 earnings report with consensus estimates indicating fundamental weakness, including a projected 28.6% year-over-year decline in EPS to $0.15 and a 0.2% decrease in revenue to $804.53 million. Despite these bearish headline figures, proprietary analytics suggest a high probability of a positive earnings surprise. The key indicator is the company's Zacks Earnings ESP of +13.33%, which reflects recent upward revisions by analysts and signals emerging bullishness on near-term earnings prospects. When combined with its Zacks Rank of #3 (Hold), this configuration has historically predicted an earnings beat nearly 70% of the time. This potential is further supported by AHCO's track record of surpassing consensus EPS estimates in three of the last four quarters. The situation presents a clear divergence between the stagnant, negative consensus and more recent, dynamic analyst sentiment, positioning the stock as a compelling candidate for an upside surprise against low expectations.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo